Analysis of thousands of individual cells in multiple myeloma patients allows for a much more precise diagnosis — distinguishing asymptomatic, early-stage patients from those with full-blown disease — and may guide treatment choices toward a more personalized approach, a study shows.
The study, “Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma,” was published in Nature Medicine.
Multiple myeloma occurs when the cells that make antibodies — called plasma cells — start dividing out of control, eventually leading to disease. Although there have been significant improvements in treatment in recent years, many therapies still aren’t curative, and most patients relapse.
read more at: https://myelomaresearchnews.com/2019/02/01/single-cell-profiling-may-improve-diagnosis-treatment/